Stanford's Richard Lafayette discusses 36-week povetacicept data in IgA nephropathy, including proteinuria, hematuria, and safety findings. Povetacicept, a dual inhibitor of B-cell activating factor ...

Most Medicaid enrollees who lost coverage during the unwinding were removed for procedural reasons, and expansion adults will ...

Anti-CGRP antibody exposure near conception was linked to higher spontaneous abortion risk in migraine, while propranolol was not, a cohort study found. Exposure to anticalcitonin gene-related peptide ...

Combined MRI and ultrasound raised sensitivity for bowel and uterosacral ligament endometriosis but reduced specificity in a prospective cohort study. Investigators at Stockholm South General Hospital ...

Dr. Haumschild compares SGLT2 inhibitors and GLP-1 receptor agonists as evidence in both classes keeps evolving. He acknowledges GLP-1s carry real budget impact that payers cannot ...

The influx of novel therapies is expanding treatment options for patients with cancer, but distance, infrastructure, and ...

In “Immunotherapy in MSI-High and dMMR mCRC,” Dr. Strickler discusses how immune checkpoint inhibition has reshaped treatment ...

Real-world evidence indicates that longer biologic dosing intervals are associated with higher persistence and fewer ...

Population Health, Equity & Outcomes | Journals | The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.